0% Complete
صفحه اصلی
/
4th international edition and 13th Iranian Conference on Bioinformatics
New inhibitors of the Toxoplasmosis by in-silico drug repurposing
نویسندگان :
Milad Jaberi
1
Masoud Aliyar
2
Mosleh Kadkhodamohammadi
3
Parva Karimimousivandi
4
1- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2- Faculty of Science, Golestan university, Shahid Beheshti Street, Gorgan, Golestan province, Iran
3- 2. Faculty of Medicine, Central Building, Tabriz University of Medical Sciences, University Street, Tabriz, Iran
4- 3. Friedrich Schiller University Jena, faculty of sciences, Fürstengraben 1, 07743 Jena, Germany
کلمات کلیدی :
Toxoplasma Gondii،Drug repurposing،Docking،Molecular Dynamics
چکیده :
Introduction: The common treatment for toxoplasmosis was pyrimethamine. It has been noticed in recent years that this parasite becomes resistant to this treatment and it thus needs immediate alternative therapies. Materials and Methods: In this study, using drug re-purposing and in silico methods we tried to make selective treatment by inhibiting the Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii which does not exist in mammalians. We screened the FDA approved drugs by molecular docking and, after ranking them by their binding energies and inspecting the top scoring ones, we selected Cefpiramide, Ceftriaxone and Cefotiam as the hit compounds. Afterwards, we used molecular dynamic simulations to evaluate the hit compounds in a much more realistic environment. Results: Through analyzing the results, we have found that all of the hit compounds are effective and can be strongly bound to the active site of the protein. They may therefore be potential candidates for the inhibition of Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii. Conclusion: Given that the predicted compounds are FDA approved drugs, their toxicity profiles are established and their potentially predicted use can be evaluated in clinical trials.
لیست مقالات
لیست مقالات بایگانی شده
Element-Specific Estimation of Background Mutation Rates in Whole Cancer Genomes Through Transfer Learning
ّFarideh Bahari - Reza Ahangari Cohan - Hesam Montazeri
Identification of circRNA-miRNA-mRNA Interaction in Myocardial Infarction
Amir Hesam Pahlevani - Ashkan Nazari - Kiarash Zare - Mohammad Ghorbani - Abdolhakim Aalkamel - Mohammad Mehdi Naghizadeh
Molecular Investigation of Periplasmic Sensor Histidine Kinase Interactions in Regulating UV Shield Formation of Cyanobacteria Nostoc Sp
Maryam Eskafi - Maryam Azimzadeh Irani
Accelerating Diffusion-Based Graph Generative Models for De Novo Drug Design via Hessian Trace Approximation
Negin Bagherpour - AmirHossein Heidari - Alireza Fotouhi Siahpirani
Investigation of the interaction between 2-aminothiazole and bovine serum albumin (BSA), using the methods of molecular docking calculations and density functional theory (DFT)
Forough Pakzadi - Yaghub Pazhang - Ebrahim Nemati-Kande
Simultaneous overexpression of CD70 and downregulation of CD84 as a prognostic marker for glucocorticoid resistance in B cell Acute lymphoblastic leukemia
Mohammad Hossein Shakib Manesh - Soheila Rahgozar
Fluidity of normal and cancer cell membranes: A molecular dynamics investigation
Elahe Hoseinnia - Mahboobeh Zarrabi
Computational study on the inhibitory potential of fungal metabolites against HIV-1 RT
Zohreh Sahhaf Razavi - Ali Ramazani - Armin Zarei
Investigating and identifying the expression profile of genes involved in human Lung Cancer using transcriptome data
Fatemeh Amiri - , Mostafa Rafiepour - Reza Mahdian - Farinaz Behfarjam
Comprehensive Analysis of DCLK Family Kinases in Gastrointestinal Cancers and Neoplastic Progression
Zahra Salehi - Leili Rejali - Moein Piroozkhah - Pooya Jalali - Ali Aghajani - Mahsa Saeedi Niyasar - Binazir Khanabadi - Amir Sadeghi - Ehsan Nazemalhossein Mojarad
بیشتر
ثمین همایش، سامانه مدیریت کنفرانس ها و جشنواره ها - نگارش 42.7.0